Fundz

Qur Alis reported raising $60 Million in an initial SEC Form D filing, from an offering of $88 Million

PRIVATEMar 13, 2023$60M of $88M raised

Amount Raised

$60 Million

$60 Million sold, per SEC Form D (first sale Dec 20, 2022)

Round Type

Venture

CambridgeBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

QurAlis raised $60 Million in a funding round, dated December 20, 2022. QurAlis is based in Cambridge, Massachusetts, United States.

How much did QurAlis raise?
QurAlis raised $60 Million in a funding round on December 20, 2022.
What does QurAlis do?
QurAlis is a pioneering neuroscience company dedicated to developing precision medicines that target the root causes of neurodegenerative and neurological diseases.
Where is QurAlis based and how big is it?
QurAlis is based in Cambridge, Massachusetts, United States. Fundz records about 94 employees.
Who are the decision-makers at QurAlis?
Fundz holds 1 contact at QurAlis, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as QurAlis that raised within 45 days of this round, from Fundz verified event records.

  • Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
  • ADARx Pharmaceuticals, Inc. raised $46M on January 26, 2023.
  • ADARx Pharmaceuticals, Inc. raised $46M (Funding Round) on January 20, 2023.
  • Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
  • BehaVR raised an undisclosed amount (Series B) on December 13, 2022.
  • NewcelX raised $10M on December 13, 2022.

Who to call at QurAlis, and when

A new round usually means QurAlis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day QurAlis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at QurAlis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at QurAlis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

QurAlis

Location

Cambridge, Massachusetts, United States

About

QurAlis is a pioneering neuroscience company dedicated to developing precision medicines that target the root causes of neurodegenerative and neurological diseases. With leading expertise in amyotrophic lateral sclerosis (ALS), the company is committed to translating scientific breakthroughs into transformative therapies. Guided by collaboration, scientific rigor, and compassion, QurAlis is advancing a robust pipeline of disease-modifying treatments driven by genetics and clinical biomarkers to improve the lives of patients with severe neurological conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment QurAlis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDaniel E., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for QurAlis's next move

See what Strategic adds

QurAlis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.